18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: A radiolabeling and PET validation study

Physics in Medicine and Biology

Volumn 52, Issue 24, 2007, Pages 7397-7408

  Selwyn, R G ^a   Avila Rodriguez, M A ^a   Converse, A K ^b   Hampel, J A ^b   Jaskowiak, C J ^c   McDermott, J C ^c   Warner, T F ^a   Nickles, R J ^a   Thomadsen, B R ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERES; POSITRON EMISSION TOMOGRAPHY; RADIOLOGY;

MACROAGGREGATED ALBUMIN (MAA); VALIDATION STUDY;

TUMORS;

MICROSPHERE; RESIN; YTTRIUM 90; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; YTTRIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HISTOLOGY; IMAGING; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIVER TUMOR; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; VALIDATION STUDY; ANIMAL; ARTIFICIAL EMBOLISM; HUMAN; LIVER CELL CARCINOMA; METHODOLOGY; PATHOLOGY; RADIATION DOSE; RAT; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MICROSPHERES; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YTTRIUM RADIOISOTOPES;

EID: 36949005413     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/52/24/013     Document Type: Article

References (44)

1. Akabani G, Hawkins W G, Eckblade M B and Leichner P K 1997 Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete fourier transform convolution J. Nucl. Med. 38 308-14
2. Alison M and Lovell M 2005 Liver cancer: the role of stem cells Cell Prolif. 38 407-21
3. 90Y: a comparative study AIP Conf. Proc. 854 45-7
4. 90Y SIR-Spheres: a radiolabeling and stability study Nucl. Med. Biol. 34 585-90
5. Blanchard R, Morrow I and Sutherland J 1989 Treatment of liver tumors with yttrium-90 microspheres alone Can. Assoc. Radiol. J. 40 206-10
6. Breedis V and Young G 1954 The blood supply of neoplasms in the liver Am. J. Pathol. 30 969
7. Buchholz H, Herzog H, Förster G, Reber H, Nickel O, Rösch F and Bartenstein P 2003 PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction Eur. J. Nucl. Med. Mol. Imaging 30 716-20
8. Campbell A M, Bailey I H and Burton M A 2000 Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy Phys. Med. Biol. 45 1023-33
9. 99mTc-MAA) uptake by colorectal liver metastases to response following selective internal radiation therapy (SIRT) BMC Nucl. Med. 5 online
10. Erdi A K, Yorke E D, Loew M H, Erdi Y E, Sarfaraz M and Wessels B W 1998 Use of the fast hartley transform for three-dimensional dose calculation in radionuclide therapy Med. Phys. 25 2226-33
11. Flux G, Bardies M, Monsieurs M, Savolainen S, Strand S E and Lassman M 2006 The impact of PET and SPECT on dosimetry for targeted radionuclide therapy Z. Med. Phys. 16 47-59
12. Fox R, Klemp P, Egan G, Mina L, Burton M and Gray B 1991 Dose distribution following selective internal radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 21 463-7
13. Geworski L, Knoop B O, de Wit M, Ivančević V, Bares R and Munz D L 2002 Multicenter comparison of calibration and cross calibration of PET scanners J. Nucl. Med. 43 635-9
14. Giap H B, Macey D J, Bayouth J E and Boyer A L 1995 Validation of a dose-point kernel convolution technique for internal dosimetry Phys. Med. Biol. 40 365-81
15. Haron M J, Wan Yunus W M Z, Wasay S A, Uchiumi A and Tokunaga S 1995 Sorption of fluoride ions from aqueous solutions by a yttrium-loaded poly (hydroxamic acid) resin Int. J. Environ. Stud. 48 245-55
16. Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G and Gray B 2004 Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J. Surg. Oncol. 88 78-85
17. Ho S, Lau W, Leung T, Chan M, Johnson P and Li A 1997a Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer Eur. J. Nucl. Med 24 293-8
18. 99Tc macroaggregated albumin Br. J. Radiol. 70 823-8
19. Ho S, Lau W, Leung T and Johnson P 1998 Internal radiation therapy for patients with primary or metastatic hepatic cancer Am. Cancer Soc. 83 1894-907
20. Houle S, Yip T, Shepherd F, Rotstein L, Sniderman K, Theis E, Cawthorn R and Richmond-Cox K 1989 Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres Radiology 172 857-60
21. Howell R W et al 1999 The MIRD perspective J. Nucl. Med. 40 37S-44S
22. 90Y microspheres in man: review of four explanted whole livers Int. J. Radiat. Oncol. Biol. Phys. 60 1552-63
23. Lau W, Leung W, Ho S, Leung N, Chan N, Lin J, Metreweli C and Li A K C 1994 Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study Br. J. Cancer 70 994-9
24. Loening A and Gambhir S 2003 AMIDE: a free software tool for multi-modality medical image analysis Mol. Imaging 2 131-7
25. Moroz P, Anderson J E, van Hazel G and Gray B N 2001 Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume J. Surg. Oncol. 78 248-52
26. National Research Council 1996 Guide for the Care and use of Laboratory Animals (Washington, DC: National Academy Press)
27. O'brien C A, Pollett A, Gallinger S and Dick J E 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 106-10
28. Pillai K M, McKeever P E, Knutsen C A, Terrio P A, Prieskorn D M and Ensminger W D 1991 Microscopic analysis of arterial microsphere distribution in rabbit liver and hepatic vx2 tumor Sel. Cancer Ther. 7 39-48
29. Rousset O and Zaidi H 2006 Correction for partial volume effects in emission tomography Quantitative Analysis in Nuclear Medicine Imaging ed Zaidi H (New York: Springer) pp 236-71
30. 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: 1. Technical and methodologic considerations J. Vasc. Intervent. Radiol. 17 1251-78
31. Sarfaraz M, Kennedy A S, Lodge M A, Li X A, Wu X and Yu C X 2004 Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma Med. Phys. 31 2449-53
32. Seo T, Oh J, Lee D, Ko Y and Yoon A 2001 Radiologic anatomy of the rabbit liver on hepatic venography, arteriography, portography, and cholangiography Invest. Radiol. 36 186-92
33. 90Sr Appl. Radiat. Isot. 65 318-27
34. Shen S, DeNardo G L, Yuan A, DeNardo D A and DeNardo S 1994 Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung J. Nucl. Med. 35 1381-9
35. Simon N and Feitelberg S 1967 Scanning bremsstrahlung of yttrium-90 microspheres injected intra-arterially Radiology 88 719-24
36. 2O Med. Phys. 19 105-14
37. Simpkin D J and Mackie T R 1989 EGS4 Monte Carlo determination of the beta dose kernel in water Med. Phys. 17 179-86
38. Stribley K, Gray B, Chmiel R, Heggie J and Bennett R 1983 Internal radiotherapy for hepatic metastases: I. The homogeneity of hepatic arterial blood flow J. Surg. Res. 34 17-24
39. Tokunaga S, Haron M J, Wasay S A, Wong K F, Laosangthum K and Uchiumi A 1995 Removal of fluoride ions from aqueous solutions by multivalent metal compounds Int. J. Environ. Stud. 48 17-28
40. Welsh J S, Kennedy A S and Thomadsen B 2006 Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma Int. J. Radiat. Oncol. Biol. Phys. 66 S62-S73
41. Westerterp M, Prium J, Oyen W, Hoekstra O, Paans A, Visser E, van Lanschot J, Sloof G and Boellaard R 2007 Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution, and ROI definition parameters Eur. J. Nucl. Med. Mol. Imaging 34 392-404
42. Wong C et al 2006 Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma Cancer Biother. Radiopharm. 21 305-13
43. Wu X Z and Chen D 2006 Origin of hepatocellular carcinoma: role of stem cells J. Gastroenterol. Hepatol. 21 1093-8
44. Zaidi H and Hasegawa B 2006 Overview of nuclear medical imaging Quantitative Analysis in Nuclear Medicine Imaging ed Zaidi H (New York: Springer) pp 1-34